Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pilocarpine ocular inserts

R Bensinger, D H Shin, M A Kass

    Investigative Ophthalmology
    |December 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pseudorapidity distribution of charged particles in d+Au collisions at sqrt[sNN]=200 GeV.

    Physical review letters·2004
    Same author

    Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.

    Experimental dermatology·2004
    Same author

    Pressure simulation of orthodontic force in osteoblasts: a pilot study.

    Orthodontics & craniofacial research·2004
    Same author

    Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.

    Experimental dermatology·2004
    Same author

    Upregulation of MCAM in primary bronchial epithelial cells from patients with COPD.

    The European respiratory journal·2003
    Same author

    Centrality dependence of charged-hadron transverse-momentum spectra in d+Au collisions at sqrt[s(NN)]=200 GeV.

    Physical review letters·2003
    Same journal

    Experimental aspergillosis.

    Investigative ophthalmology·2014
    Same journal

    Inhibition of prostaglandin-mediated ocular inflammatory responses by 4-biphenylacetic acid.

    Investigative ophthalmology·1976
    Same journal

    Normal interaction of plasma retinol-binding protein from retinitis pigmentosa with bovine pigment epithelium.

    Investigative ophthalmology·1976
    Same journal

    Retinol- and retinoic acid-binding proteins: occurrence in human retina and absence from human cultured fibroblasts.

    Investigative ophthalmology·1976
    Same journal

    Electrical parameters of the isolated cornea of the dogfish, Squalus acanthias.

    Investigative ophthalmology·1976
    Same journal

    Endothelial damage from intraocular lens insertion.

    Investigative ophthalmology·1976
    See all related articles

    New drug delivery using soluble inserts effectively lowered intraocular pressure in ocular hypertensive patients. This method showed minimal intolerance and sustained pressure reduction for over 24 hours, offering a promising therapeutic option.

    Area of Science:

    • Ophthalmology
    • Pharmacology
    • Biomaterials Science

    Background:

    • Ocular hypertension is a risk factor for glaucoma.
    • Current treatments for ocular hypertension have limitations.

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of pilocarpine delivered via a synthetic biosoluble matrix in ocular hypertensive subjects.
    • To assess the duration of intraocular pressure reduction.

    Main Methods:

    • Pilocarpine was administered using a synthetic biosoluble insert placed in the conjunctival cul-de-sac.
    • Intraocular pressure was monitored in a group of ocular hypertensive individuals.

    Main Results:

    • A satisfactory reduction in intraocular pressure was achieved.

    Related Experiment Videos

  • The treatment demonstrated minimal subject intolerance.
  • Significant pressure reduction lasted for over 24 hours in some cases.
  • Conclusions:

    • Drug delivery via soluble inserts is a promising therapeutic approach for ocular hypertension.
    • This method offers a convenient and effective alternative to conventional therapies.